Teladoc Health (TDOC) Net Cash Flow (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Net Cash Flow data on file, last reported at -$29.5 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 72.36% year-over-year to -$29.5 million; the trailing twelve-month figure through Mar 2026 stood at -$446.2 million (down 563.79% YoY), and the FY2025 full-year result was -$523.3 million, down 394.09% from the prior year.
• Net Cash Flow slipped to -$29.5 million in Q1 2026, from $54.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $91.8 million in Q4 2023 to a low of -$518.2 million in Q2 2025.
• A 5-year average of -$8.4 million and a median of $46.3 million in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 472.36% in 2023 and plunged 900.43% in 2025, its largest moves.
• Tracing TDOC's Net Cash Flow over 5 years: stood at $16.0 million in 2022, then surged by 472.36% to $91.8 million in 2023, then plunged by 36.48% to $58.3 million in 2024, then slipped by 6.5% to $54.5 million in 2025, then plunged by 154.02% to -$29.5 million in 2026.
• Business Quant data shows TDOC's Net Cash Flow at -$29.5 million in Q1 2026, $54.5 million in Q4 2025, and $47.0 million in Q3 2025.